Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying
Display Omitted
Gespeichert in:
| Autor*in: |
Zhang, Hairui [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021 |
|---|
| Schlagwörter: |
|---|
| Übergeordnetes Werk: |
Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:605 ; year:2021 ; day:10 ; month:08 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijpharm.2021.120831 |
|---|
| Katalog-ID: |
ELV054743192 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV054743192 | ||
| 003 | DE-627 | ||
| 005 | 20230624213656.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijpharm.2021.120831 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001467.pica |
| 035 | |a (DE-627)ELV054743192 | ||
| 035 | |a (ELSEVIER)S0378-5173(21)00636-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.61 |2 bkl | ||
| 100 | 1 | |a Zhang, Hairui |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying |
| 264 | 1 | |c 2021 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Nanoparticle |2 Elsevier | |
| 650 | 7 | |a CRISPR-Cas9 |2 Elsevier | |
| 650 | 7 | |a Thin-film freeze-drying |2 Elsevier | |
| 650 | 7 | |a Pulmonary delivery |2 Elsevier | |
| 650 | 7 | |a Dry powder |2 Elsevier | |
| 650 | 7 | |a PEGylated chitosan |2 Elsevier | |
| 700 | 1 | |a Zhang, Yajie |4 oth | |
| 700 | 1 | |a Williams, Robert O. |4 oth | |
| 700 | 1 | |a Smyth, Hugh D.C. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Nigolian, H. ELSEVIER |t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |d 2022 |g New York, NY [u.a.] |w (DE-627)ELV008932840 |
| 773 | 1 | 8 | |g volume:605 |g year:2021 |g day:10 |g month:08 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2021.120831 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.61 |j Innere Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 605 |j 2021 |b 10 |c 0810 |h 0 | ||
| author_variant |
h z hz |
|---|---|
| matchkey_str |
zhanghairuizhangyajiewilliamsrobertosmyt:2021----:eeomnopgltdhtsnrsra9rpwesoploayeie |
| hierarchy_sort_str |
2021 |
| bklnumber |
44.61 |
| publishDate |
2021 |
| allfields |
10.1016/j.ijpharm.2021.120831 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001467.pica (DE-627)ELV054743192 (ELSEVIER)S0378-5173(21)00636-0 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Zhang, Hairui verfasserin aut Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticle Elsevier CRISPR-Cas9 Elsevier Thin-film freeze-drying Elsevier Pulmonary delivery Elsevier Dry powder Elsevier PEGylated chitosan Elsevier Zhang, Yajie oth Williams, Robert O. oth Smyth, Hugh D.C. oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:605 year:2021 day:10 month:08 pages:0 https://doi.org/10.1016/j.ijpharm.2021.120831 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 605 2021 10 0810 0 |
| spelling |
10.1016/j.ijpharm.2021.120831 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001467.pica (DE-627)ELV054743192 (ELSEVIER)S0378-5173(21)00636-0 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Zhang, Hairui verfasserin aut Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticle Elsevier CRISPR-Cas9 Elsevier Thin-film freeze-drying Elsevier Pulmonary delivery Elsevier Dry powder Elsevier PEGylated chitosan Elsevier Zhang, Yajie oth Williams, Robert O. oth Smyth, Hugh D.C. oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:605 year:2021 day:10 month:08 pages:0 https://doi.org/10.1016/j.ijpharm.2021.120831 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 605 2021 10 0810 0 |
| allfields_unstemmed |
10.1016/j.ijpharm.2021.120831 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001467.pica (DE-627)ELV054743192 (ELSEVIER)S0378-5173(21)00636-0 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Zhang, Hairui verfasserin aut Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticle Elsevier CRISPR-Cas9 Elsevier Thin-film freeze-drying Elsevier Pulmonary delivery Elsevier Dry powder Elsevier PEGylated chitosan Elsevier Zhang, Yajie oth Williams, Robert O. oth Smyth, Hugh D.C. oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:605 year:2021 day:10 month:08 pages:0 https://doi.org/10.1016/j.ijpharm.2021.120831 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 605 2021 10 0810 0 |
| allfieldsGer |
10.1016/j.ijpharm.2021.120831 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001467.pica (DE-627)ELV054743192 (ELSEVIER)S0378-5173(21)00636-0 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Zhang, Hairui verfasserin aut Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticle Elsevier CRISPR-Cas9 Elsevier Thin-film freeze-drying Elsevier Pulmonary delivery Elsevier Dry powder Elsevier PEGylated chitosan Elsevier Zhang, Yajie oth Williams, Robert O. oth Smyth, Hugh D.C. oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:605 year:2021 day:10 month:08 pages:0 https://doi.org/10.1016/j.ijpharm.2021.120831 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 605 2021 10 0810 0 |
| allfieldsSound |
10.1016/j.ijpharm.2021.120831 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001467.pica (DE-627)ELV054743192 (ELSEVIER)S0378-5173(21)00636-0 DE-627 ger DE-627 rakwb eng 610 VZ 44.61 bkl Zhang, Hairui verfasserin aut Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying 2021 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticle Elsevier CRISPR-Cas9 Elsevier Thin-film freeze-drying Elsevier Pulmonary delivery Elsevier Dry powder Elsevier PEGylated chitosan Elsevier Zhang, Yajie oth Williams, Robert O. oth Smyth, Hugh D.C. oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:605 year:2021 day:10 month:08 pages:0 https://doi.org/10.1016/j.ijpharm.2021.120831 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 605 2021 10 0810 0 |
| language |
English |
| source |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:605 year:2021 day:10 month:08 pages:0 |
| sourceStr |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:605 year:2021 day:10 month:08 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Innere Medizin |
| institution |
findex.gbv.de |
| topic_facet |
Nanoparticle CRISPR-Cas9 Thin-film freeze-drying Pulmonary delivery Dry powder PEGylated chitosan |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| authorswithroles_txt_mv |
Zhang, Hairui @@aut@@ Zhang, Yajie @@oth@@ Williams, Robert O. @@oth@@ Smyth, Hugh D.C. @@oth@@ |
| publishDateDaySort_date |
2021-01-10T00:00:00Z |
| hierarchy_top_id |
ELV008932840 |
| dewey-sort |
3610 |
| id |
ELV054743192 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV054743192</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624213656.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2021.120831</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001467.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV054743192</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(21)00636-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhang, Hairui</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticle</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CRISPR-Cas9</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Thin-film freeze-drying</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pulmonary delivery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dry powder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PEGylated chitosan</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Yajie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Williams, Robert O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Smyth, Hugh D.C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:605</subfield><subfield code="g">year:2021</subfield><subfield code="g">day:10</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2021.120831</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">605</subfield><subfield code="j">2021</subfield><subfield code="b">10</subfield><subfield code="c">0810</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Zhang, Hairui |
| spellingShingle |
Zhang, Hairui ddc 610 bkl 44.61 Elsevier Nanoparticle Elsevier CRISPR-Cas9 Elsevier Thin-film freeze-drying Elsevier Pulmonary delivery Elsevier Dry powder Elsevier PEGylated chitosan Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying |
| authorStr |
Zhang, Hairui |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008932840 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.61 bkl Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying Nanoparticle Elsevier CRISPR-Cas9 Elsevier Thin-film freeze-drying Elsevier Pulmonary delivery Elsevier Dry powder Elsevier PEGylated chitosan Elsevier |
| topic |
ddc 610 bkl 44.61 Elsevier Nanoparticle Elsevier CRISPR-Cas9 Elsevier Thin-film freeze-drying Elsevier Pulmonary delivery Elsevier Dry powder Elsevier PEGylated chitosan |
| topic_unstemmed |
ddc 610 bkl 44.61 Elsevier Nanoparticle Elsevier CRISPR-Cas9 Elsevier Thin-film freeze-drying Elsevier Pulmonary delivery Elsevier Dry powder Elsevier PEGylated chitosan |
| topic_browse |
ddc 610 bkl 44.61 Elsevier Nanoparticle Elsevier CRISPR-Cas9 Elsevier Thin-film freeze-drying Elsevier Pulmonary delivery Elsevier Dry powder Elsevier PEGylated chitosan |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
y z yz r o w ro row h d s hd hds |
| hierarchy_parent_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| hierarchy_parent_id |
ELV008932840 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008932840 |
| title |
Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying |
| ctrlnum |
(DE-627)ELV054743192 (ELSEVIER)S0378-5173(21)00636-0 |
| title_full |
Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying |
| author_sort |
Zhang, Hairui |
| journal |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| journalStr |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Zhang, Hairui |
| container_volume |
605 |
| class |
610 VZ 44.61 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Zhang, Hairui |
| doi_str_mv |
10.1016/j.ijpharm.2021.120831 |
| dewey-full |
610 |
| title_sort |
development of pegylated chitosan/crispr-cas9 dry powders for pulmonary delivery via thin-film freeze-drying |
| title_auth |
Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying |
| url |
https://doi.org/10.1016/j.ijpharm.2021.120831 |
| remote_bool |
true |
| author2 |
Zhang, Yajie Williams, Robert O. Smyth, Hugh D.C. |
| author2Str |
Zhang, Yajie Williams, Robert O. Smyth, Hugh D.C. |
| ppnlink |
ELV008932840 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.ijpharm.2021.120831 |
| up_date |
2024-07-06T22:34:38.545Z |
| _version_ |
1803870827756650496 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV054743192</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624213656.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2021.120831</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001467.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV054743192</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(21)00636-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zhang, Hairui</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Development of PEGylated chitosan/CRISPR-Cas9 dry powders for pulmonary delivery via thin-film freeze-drying</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticle</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CRISPR-Cas9</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Thin-film freeze-drying</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pulmonary delivery</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dry powder</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PEGylated chitosan</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Yajie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Williams, Robert O.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Smyth, Hugh D.C.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:605</subfield><subfield code="g">year:2021</subfield><subfield code="g">day:10</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2021.120831</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">605</subfield><subfield code="j">2021</subfield><subfield code="b">10</subfield><subfield code="c">0810</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.40149 |